NGSP News

Updated 03/27/2019

2019 Manufacturer Forum at the AACC

The annual NGSP/IFCC Manufacturer Forum will take place in Anaheim, CA from 2:00PM to 4:00PM on Monday, August 5 in room California B of the Hilton Anaheim. Please contact NGSP Network Coordinator Dr. Randie Little (LittleR@health.missouri.edu) if you wish to attend.

New Certification Criteria beginning in 2019

The NGSP certification criteria have been tightened beginning with January 2019 certifications; the changes are summarized in the table below.

Certification
Type

2014-2018 Certification Criterion

New Certification Criterion (2019)

Manufacturer

37 of 40 results within ± 6%

36 of 40 results within ± 5%

Level I Lab

38 of 40 results within ± 6%

37 of 40 results within ± 5%

Level II Lab

37 of 40 results within ± 6%

36 of 40 results within ± 5%

New CAP Criterion beginning in 2020

The acceptable limits for passing the CAP GH HbA1c surveys will be tightened from the current +/-6% to +/-5% beginning with the first 2020 survey.

2018 NGSP Meetings

The NGSP Clinical Advisory Committee meeting was held at the 78th annual American Diabetes Association Scientific Sessions in Orlando, FL. The NGSP Steering Committee meeting, NGSP/IFCC Manufacturer Forum and the C-peptide Standardization meeting were held in Chicago, IL during the American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo. Minutes of these meetings are now posted.